14-20693686-A-T

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2

The NM_001097577.3(ANG):​c.122A>T​(p.Lys41Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00178 in 1,614,170 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00095 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 8 hom. )

Consequence

ANG
NM_001097577.3 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:6

Conservation

PhyloP100: 0.204
Variant links:
Genes affected
ANG (HGNC:483): (angiogenin) The protein encoded by this gene is a member of the RNase A superfamily though it has relatively weak ribonucleolytic activity. This protein is a potent mediator of new blood vessel formation and thus, in addition to the name RNase5, is commonly called angiogenin. This protein induces angiogenesis after binding to actin on the surface of endothelial cells. This protein also accumulates at the nucleolus where it stimulates ribosomal transcription. Under stress conditions this protein translocates to the cytosol where it hydrolyzes cellular tRNAs and influences protein synthesis. A signal peptide is cleaved from the precursor protein to produce a mature protein which contains a nuclear localization signal, a cell binding motif, and a catalytic domain. This protein has been shown to be both neurotrophic and neuroprotective and the mature protein has antimicrobial activity against some bacteria and fungi, including S. pneumoniae and C. albicans. Due to its effect on rRNA production and angiogenesis this gene plays important roles in cell growth and tumor progression. Mutations in this gene are associated with progression of amyotrophic lateral sclerosis (ALS). This gene and the neighboring RNase4 gene share promoters and 5' exons though each gene then splices to a distinct 3' exon containing the complete coding region of each gene. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2020]
RNASE4 (HGNC:10047): (ribonuclease A family member 4) The protein encoded by this gene belongs to the pancreatic ribonuclease family. It plays an important role in mRNA cleavage and has marked specificity towards the 3' side of uridine nucleotides. Alternative splicing results in four transcript variants encoding the same protein. This gene and the gene that encodes angiogenin share promoters and 5' exons. Each gene splices to a unique downstream exon that contains its complete coding region. [provided by RefSeq, Aug 2013]
EGILA (HGNC:54482): (EGFR interacting lncRNA)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.24151713).
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000946 (144/152276) while in subpopulation SAS AF= 0.00249 (12/4820). AF 95% confidence interval is 0.00144. There are 1 homozygotes in gnomad4. There are 58 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 144 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ANGNM_001097577.3 linkuse as main transcriptc.122A>T p.Lys41Ile missense_variant 2/2 ENST00000397990.5 NP_001091046.1
RNASE4NM_002937.5 linkuse as main transcriptc.-17-5669A>T intron_variant ENST00000555835.3 NP_002928.1
EGILANR_174964.1 linkuse as main transcriptn.530T>A non_coding_transcript_exon_variant 4/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ANGENST00000397990.5 linkuse as main transcriptc.122A>T p.Lys41Ile missense_variant 2/21 NM_001097577.3 ENSP00000381077 P1
RNASE4ENST00000555835.3 linkuse as main transcriptc.-17-5669A>T intron_variant 1 NM_002937.5 ENSP00000452245 P1
EGILAENST00000554286.1 linkuse as main transcriptn.709T>A non_coding_transcript_exon_variant 4/45

Frequencies

GnomAD3 genomes
AF:
0.000946
AC:
144
AN:
152158
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00163
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00118
AC:
298
AN:
251496
Hom.:
1
AF XY:
0.00123
AC XY:
167
AN XY:
135922
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00281
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00177
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.00187
AC:
2734
AN:
1461894
Hom.:
8
Cov.:
31
AF XY:
0.00188
AC XY:
1369
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00292
Gnomad4 FIN exome
AF:
0.000131
Gnomad4 NFE exome
AF:
0.00212
Gnomad4 OTH exome
AF:
0.00176
GnomAD4 genome
AF:
0.000946
AC:
144
AN:
152276
Hom.:
1
Cov.:
32
AF XY:
0.000779
AC XY:
58
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.000361
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00249
Gnomad4 FIN
AF:
0.0000942
Gnomad4 NFE
AF:
0.00163
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00145
Hom.:
0
Bravo
AF:
0.000952
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00142
AC:
172
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00153
EpiControl
AF:
0.00166

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Amyotrophic lateral sclerosis type 9 Pathogenic:1Uncertain:1Benign:1
Pathogenic, no assertion criteria providedliterature onlyOMIMAug 01, 2010- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Uncertain significance, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 30, 2019Functional analysis suggest that it disrupts protein function under certain laboratory conditions, however these results are inconsistent (Wu et al., 2007; Thiyagarajan et al., 2012); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Observed in healthy controls at the same frequency as in disease populations (van Es et al., 2011); This variant is associated with the following publications: (PMID: 19363631, 28444446, 20577002, 25382069, 22499346, 19444281, 19153377, 22522484, 23447461, 19449021, 17900154, 23047679, 17886298, 23463871, 23155438, 28430856, 22292843, 26255299, 22645277, 29895397, 19488901, 16501576, 22190368, 22384259, 23665167) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2024ANG: PM5, BS1 -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 13, 2024- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingAthena DiagnosticsOct 26, 2020- -
ANG-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 20, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.092
T
BayesDel_noAF
Uncertain
0.090
CADD
Benign
9.3
DANN
Benign
0.78
DEOGEN2
Benign
0.091
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.025
N
LIST_S2
Benign
0.68
.;T
M_CAP
Uncertain
0.093
D
MetaRNN
Benign
0.24
T;T
MetaSVM
Uncertain
0.52
D
MutationAssessor
Uncertain
2.4
M;M
MutationTaster
Benign
1.0e-7
A;A;A;A;A
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-4.0
D;D
REVEL
Uncertain
0.57
Sift
Benign
0.048
D;D
Sift4G
Benign
0.12
T;T
Polyphen
0.13
B;B
Vest4
0.27
MVP
0.78
MPC
0.59
ClinPred
0.071
T
GERP RS
0.91
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.43
gMVP
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121909536; hg19: chr14-21161845; COSMIC: COSV59012716; API